Allarity Therapeutics Inc. (ALLR)
ALLR trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.8699
+1.14% on the day
Market cap
$13.8M
Nano cap
Revenue · 2025
$320K
No prior year to compare
Net income · 2025
-$11.2M
-3509.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1860657/000143774926010310/0001437749-26-010310-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | ALLR on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001860657 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $320K |
| Net income | -$11.2M |
| Operating income | -$12.6M |
| Net margin | -3509.7% |
| Operating margin | -3939.1% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $14.7M |
| Total assets | $18.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 43.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B3 | 2026-04-27 |
| Latest annual report FORM 10-K | 10-K | 2026-03-30 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-14 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-01 |
| Latest proxy PROXY STATEMENT | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 400 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| HIND | Vyome Holdings Inc. | $1.97 | -1.99% | $13.8M |
| TVRD | Tvardi Therapeutics Inc. | $1.04 | -1.89% | $13.9M |
| KTTA | Pasithea Therapeutics Corp. | $0.4238 | -5.30% | $14.2M |
| RKTO | Rocket One Inc. | $0.5708 | -4.85% | $14.2M |
| GTBP | GT Biopharma Inc. | $6.50 | -4.41% | $13.4M |
| LPCN | Lipocine Inc. | $1.62 | -2.41% | $13.4M |
| BFRI | Biofrontera Inc. | $0.8922 | -3.56% | $13.3M |
| CLRB | Cellectar Biosciences Inc. | $1.39 | -2.80% | $13.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier